Deucravacitinib for Patients With Moderate/Severe Psoriasis: A Real-Life Experience in Italy
Recruiting
200 enrolled
SKINERGY
Recruiting
840 enrolled
T Cell Repertoire Analysis of Immune Mediated Skin Diseases
Completed
426 enrolled
QUANTUM
Enrolling by invitation
3,000 enrolled
ADVANCE
Phase 3 Completed
595 enrolled 19 charts
Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
Recruiting
20,000 enrolled
A Study to Evaluate the Efficacy and Safety of Secukinumab in Adult Patients With Skin Types IV-VI With Moderate to Severe Plaque Psoriasis
Phase 4 Completed
20 enrolled
A Dose Finding Study of AEB071 Assessing Psoriasis Area and Severity Index in Patients With Plaque Psoriasis
Phase 2 Completed
336 enrolled
A Phase 2b Study of Baricitinib in Participants With Moderate to Severe Psoriasis
Phase 2 Completed
271 enrolled 32 charts
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Asian Subjects With Moderate To Severe Plaque Psoriasis
Phase 3 Completed
266 enrolled 58 charts
Evaluate Safety and Tolerability of Calcipotriene Foam 0.005% in Pediatric Subjects With Mild/Moderate Plaque Psoriasis
Phase 1 Completed
36 enrolled
A Study To Evaluate The Effects And Safety Of Treatment, Treatment Withdrawal, Followed By Re-Treatment With CP-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Phase 3 Completed
666 enrolled 110 charts
A Phase 3, Multi Site, Randomized, Double Blind, Placebo Controlled Study Of The Efficacy And Safety Comparing CP- 690,550 And Etanercept In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Phase 3 Completed
1,101 enrolled 46 charts
Safety and Efficacy of UC-MSCs in Patients With Plaque Psoriasis
Phase 1 Unknown
57 enrolled
BioUV2017
Phase NA Unknown
240 enrolled
A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Phase 3 Terminated
2,867 enrolled 77 charts
REFINE
Phase 3 Completed
310 enrolled 32 charts
Tofacitinib Ointment For Chronic Plaque Psoriasis
Phase 2 Completed
476 enrolled 33 charts
A Long Term Study To Evaluate The Safety, Tolerability And Efficacy Of CP-690,550 In Patients With Moderate To Severe Plaque Psoriasis And/Or Psoriatic Arthritis
Phase 3 Completed
95 enrolled 37 charts
A One-Year Study To Evaluate The Effects And Safety Of CP-690,550 In Patients With Moderate To Severe Chronic Plaque Psoriasis
Phase 3 Completed
901 enrolled 56 charts
Evaluating the Safety of Etanercept 50 mg Twice Weekly in Subjects With Psoriasis
Phase 3 Completed
600 enrolled
OnderHUIDs
Phase 4 Completed
50 enrolled
The RATIO: Registry of Infections and Lymphoma in Patients Treated With TNF-a Antagonists
Unknown